invivyd

Invivyd is a clinical-stage biopharmaceutical company focused on developing antibody-based therapies to protect against serious viral infectious diseases. The company leverages a proprietary integrated technology platform to assess, monitor, develop, and adapt antibody solutions, with a mission to deliver protection from serious viral respiratory diseases, beginning with COVID-19.